共 33 条
Application of porous membrane protected micro-solid-phase-extraction combined with gas chromatography-mass spectrometry for the determination of estrogens in ovarian cyst fluid samples
被引:56
作者:
Kanimozhi, Sivarajan
[2
]
Basheer, Chanbasha
[1
]
Narasimhan, Kothandaraman
[3
]
Liu, Lin
[3
]
Koh, Stephen
[3
]
Xue, Feng
[2
]
Choolani, Mahesh
[3
]
Lee, Hian Kee
[2
]
机构:
[1] King Fahd Univ Petr & Minerals, Dept Chem, Dhahran 31261, Saudi Arabia
[2] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore
[3] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119074, Singapore
关键词:
Estrogens;
Micro-solid-phase-extraction;
Cancer risk;
Cyst fluids;
Ovarian cancer;
WATER SAMPLES;
LIQUID-CHROMATOGRAPHY;
BREAST DISEASE;
WASTE-WATER;
MICROEXTRACTION;
CANCER;
DERIVATIZATION;
ESTRONE;
WOMEN;
17-ALPHA-ETHINYLESTRADIOL;
D O I:
10.1016/j.aca.2010.12.007
中图分类号:
O65 [分析化学];
学科分类号:
070302 ;
081704 ;
摘要:
A cost effective and environmentally friendly extraction technique using porous membrane protected micro-solid phase extraction (mu-SPE) is described for the extraction of estrogens in cyst fluid samples obtained from cancer patients. A sorbent (ethylsilane (C2) modified silica) (20 mg) was packed in a porous polypropylene envelope (2 cm x 1.5 cm) whose edges were heat sealed to secure the contents. The mu-SPE device was conditioned with acetone and placed in a stirred (1:5) diluted cyst fluid sample solution (10 mL) to extract estrogens for 60 min. After extraction, the analytes were desorbed and simultaneously derivatized with a 5:1 mixture of acetone and N,O-bis(trimethylsilyl)-trifluoroacetamide. The extract (2 mu L) was analyzed by gas chromatography-mass spectrometry. Various extraction, desorption and derivatization conditions were optimized for mu-SPE. With this simple technique, low limits of detection of between 9 and 22 ng L-1 and linear range from the detection limits up to 50 mu g L-1 were achieved. The optimized method was used to extract estrogens from cyst fluid samples obtained from patients with malignant and benign ovarian tumors. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:56 / 60
页数:5
相关论文